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. Although they are unable to utilise muscle glycogen, McArdle mice adapt favourably to an 
individualised moderate-intensity endurance exercise training regime. Yet, they fail reach the 
performance capacity of healthy mice with normal glycogen availability.  
. There is a remarkable difference in the protein networks involved in muscle tissue 






. Indeed, endurance exercise training promoted the expression of only three proteins common 
to both McArdle and wild-type mice: LIMCH1, PARP1 and TIGD4.  
. In turn, trained McArdle mice presented strong expression of mitogen-activated protein 
kinase 12 (MAPK12). 
 
ABSTRACT  
McArdle disease is an inborn disorder of skeletal muscle glycogen metabolism that results in 
blockade of glycogen breakdown due to mutations in the myophosphorylase gene. We 
recently developed a mouse model carrying the homozygous p.R50X common human 
mutation (McArdle mouse), facilitating the study of how glycogen availability affects muscle 
molecular adaptations to endurance exercise training. Using quantitative differential analysis 
by liquid chromatography with tandem-mass spectrometry, we analysed the quadriceps 
muscle proteome of 16-week-old McArdle (n=5) and wild-type (WT) (n=4) mice previously 
subjected to 8-week moderate-intensity treadmill training or to an equivalent control (no 
training) period. Protein networks enriched within the differentially expressed proteins with 
training in WT and McArdle mice were assessed by hypergeometric enrichment analysis. 
Whereas endurance exercise training improved the estimated maximal aerobic capacity of 
both WT and McArdle mice as compared with controls, it was ~50% lower than normal in 
McArdle mice before and after training. We found a remarkable difference in the protein 
networks involved in muscle tissue adaptations induced by endurance exercise training 
with/without glycogen availability, and training induced the expression of only three 






protein 1 (LIMCH1), poly [ADP-ribose] polymerase 1 (PARP1–although the training effect 
was more marked in McArdle mice), and tigger transposable element derived 4 (TIGD4). 
Trained McArdle mice presented strong expression of mitogen-activated protein kinase 12 
(MAPK12). Through an in-depth proteomic analysis, we provide mechanistic insight into 
how glycogen availability affects muscle protein signalling adaptations to endurance exercise 
training.   
 




The importance of endogenous muscle glycogen as a primary fuel source during exertion 
(particularly for intense endurance bouts) has been a fundamental concept in exercise 
physiology for half a century (Bergstrom et al., 1967; Pernow & Saltin, 1971). Accordingly, 
carbohydrate-rich diets have been traditionally recommended for athletes to ensure the 
replenishment of muscle glycogen stores to meet the metabolic demands of intense training 
exercise sessions and competitions (Bartlett et al., 2015). However, training with low muscle 
glycogen availability might induce some beneficial metabolic adaptations in the muscle 
tissue, including activation of key cell signalling kinases (e.g., protein kinase AMP-activated 
catalytic subunit alpha 1 [AMPK], p38 mitogen-activated protein kinase [p38MAPK]), 






[PPARδ]) and transcriptional co-activators (e.g., peroxisome proliferator-activated receptor-
1α [PGC-1α]) (Bartlett et al., 2015), increased fat oxidation (Lane et al., 2015), or delayed 
liver glycogenolysis (Webster et al., 2016). Elucidating the muscle metabolic adaptations to 
endurance exercise training as a function of glycogen availability is of interest as it may help 
to gain insight into the mechanisms that mediate the muscle adaptations to this type of 
training. This issue can be solved effectively by studying McArdle disease because it allows 
the investigation of the effects of total unavailability of muscle glycogen on muscle 
adaptations to endurance exercise training without the need for dietary (e.g., extreme 
restrictions in carbohydrate intake) or pharmacological manipulations.   
McArdle disease (glycogen storage disease type V, OMIM® 232600) is the most 
prevalent disorder of muscle glycogen metabolism. This autosomal recessive disease is caused 
by pathogenic mutations (the most common of which is the stop codon mutation p.R50X) in 
both alleles of the PYGM gene (MIM#608455) encoding the skeletal-muscle isoform of 
glycogen phosphorylase, ‘myophosphorylase’, which leads to total deficiency of the enzyme 
(Santalla et al., 2014). Because myophosphorylase catalyses the breakdown of glycogen into 
glucose 1-phosphate in skeletal muscle fibres, patients are unable to obtain energy from their 
muscle glycogen stores (Santalla et al., 2014). This disorder provokes ‘exercise intolerance’ in 
virtually all affected individuals, which typically manifests in the form of acute crises of 
undue fatigue and muscle pain and stiffness since childhood (Lucia et al., 2012). 
Paradoxically, patients who are physically active are less severely affected than their inactive 
peers (Lucia et al., 2012). Prior non-controlled studies have reported benefits of supervised, 






patients with McArdle disease, in the form of increased peak oxygen uptake (VO2peak) (Haller 
et al., 2006; Mate-Munoz et al., 2007) associated with improvements in the muscle levels of 
two key aerobic enzymes, citrate synthase and beta-hydroxyacyl coenzyme A dehydrogenase 
(Haller et al., 2006). No other molecular data are, however, available on muscle tissue 
adaptations to training in these patients.  
We recently generated a knock-in mouse model of McArdle disease (mice homozygous 
for the pygm p.R50X mutation) (Nogales-Gadea et al., 2012; Brull et al., 2015). Because this 
model closely mimics the phenotypes observed in patients (Nogales-Gadea et al., 2012), it 
can serve as a useful tool to assess the effects of potential treatment interventions for 
McArdle disease, including endurance exercise training. It was therefore the aim of our study 
to identify key proteins and pathways involved in the endurance exercise training 
adaptations at the muscle tissue level in McArdle disease. To do this, we examined, using a 
controlled design, the effects of submaximal endurance training on the skeletal muscle 




The study received ethical institutional (Centre of Energy, Environment and Technical 
Research, CIEMAT) review board approval (reference number 179/15). Experiments were 
carried out according to the guidelines laid down by the institution's welfare committee, and 





procedures were carried out according to European and Spanish legislative and regulatory 
guidelines (European convention ETS 1 2 3, on the use and protection of vertebrate 
mammals in experimentation and for other scientific purposes, and Spanish Law 32/2007, 
and R.D. 1201/2005 on the protection and use of animals in scientific research). The 
investigators of the present study understand the ethical principles under which the Journal 
of Physiology operates and our work complies with its animal ethics checklist. Whenever 
possible, efforts were made to minimise animal discomfort (see ‘Endurance exercise training 
intervention in McArdle and wild-type mice’). 
 
Animals 
Founder p.R50X/p.R50X knock-in mice of mixed genetic background (Nogales-Gadea et al., 
2012) were backcrossed onto the wild-type CB7Bl/6J background for ten generations. All the 
animals were genotyped with LoxP-F and LoxP-R as previously reported (Nogales-Gadea et 
al., 2012).  
A total of 36 male mice (age: 8 weeks; wild-type: n=18; McArdle: n=18) were housed 
in Eurostandard type IIL microisolator cages (five mice maximum in each) under controlled 
conditions of temperature and humidity (20ºC ± 2ºC and 55% ± 10%, respectively) at the 
animal facility of the CIEMAT (registration no. ES280790000183, Madrid, Spain). The cages 
were lit (fluorescent lighting) from 7:00 a.m. to 7:00 p.m., and food (Harlan Teklad Global 
Diets 2914) and water (50 µm filtered and UV irradiated) were provided ad libitum.  







Mice were allowed to adapt to the treadmill (Harvard Apparatus; Panlab, Barcelona, Spain) 
in three sessions (on three separate days) as described (Fiuza-Luces et al., 2013); adaptation 
involved a gradual increase in running time, treadmill velocity and inclination, starting with 
placement of the mouse on the treadmill with movement at a very low speed during the first 
day (0% inclination and 0–5 cm s-1 speed for 1 min, with 0.1 mA electrical stimulation) and 
ending with a 20-min period at low running intensity on the third day (15% and 12 cm s-1, 
electrical stimulation 0.1 mA, 1 Hz, 200 ms). A total of four treadmills were used and each 
mouse was consistently trained and tested on the same treadmill. 
Maximal endurance exercise performance test  
Once the mice had adapted to the treadmill, they were subjected to a gradual test until 
exhaustion to determine total running distance as a proxy of their maximal aerobic capacity 
(Hoydal et al., 2007). The test was performed after a warm-up period of 20 min at a speed of 
12 cm s-1 (with 15% inclination), and followed a previous protocol from our group with slight 
modifications in workload increases (Fiuza-Luces et al., 2013). Thus, the initial velocity was 
5 cm∙ s-1, and this was followed by workload increases of 3 cm s-1 every 2 min until 
exhaustion, while treadmill inclination was kept constant at 15% during the whole test and 
use of electrical stimulation electrical stimulation (0.1 mA, 1 Hz, 200 ms). Mice were defined 
as exhausted when they spent more than 5 continuous seconds on the electric grid and were 









McArdle mice were paired-matched based on the total running distance they reached during 
the aforementioned test, and each pair was randomly assigned to an exercise (n=9, subjected 
to an 8-week exercise training program) or a control (‘sedentary’) group (n=9, allowed to 
freely move in the cage, but not performing the program). The same method of group 
(exercise or control) assignment and number of animals per group was applied for wild-type 
mice. 
Endurance exercise training intervention in McArdle and wild-type mice 
Training load over a period of time is the result of the combination of frequency, duration 
and intensity of the different sessions. Thus, for the training loads of the two McArdle and 
wild-type exercise groups during the 8-week period to be comparable despite their different 
fitness level at baseline, we ensured that the weekly frequency of training sessions and the 
duration and relative intensity (the latter expressed as % of the velocity reached at the end 
of the tests [Vmax]) of each session was the same for the two groups. Thus, the intervention in 
both exercise groups included 5 weekly sessions (from Monday to Friday; session duration, 
30–50 min), which was performed between 08.00 am and 12.00 pm. The duration and 
relative intensity of each session were also the same and increased gradually in the same 
manner in the two groups, beginning at low workloads in the first session (30 min at 50% of 
Vmax and 0% gradient on the first day) and ending with 50 min at 70–75% of Vmax and 15% 
gradient at the end of the program (Fiuza-Luces et al., 2013). All the sessions included a 






a cool-down period (5 min at 35% of Vmax), both at the same treadmill slope used for the 
core part. 
Whenever possible, efforts were made to minimise animal discomfort. Thus, only 
gentle tail touching was used to prompt the mice to run and no electrical stimulation was 
applied during the training sessions. In addition, because carbohydrate ingestion 30–40 min 
prior to exercise attenuates the risk of muscle damage in McArdle disease (Lucia et al., 2008) 
and thus for ethical reasons, during the hour before each session McArdle mice were fed one 
Fruit CrunchiesTM pellet (weight, 190 mg; 52% energy from carbohydrate, 20.2% protein, 
11.5% fibre, 6.3% fat, 5.1% ash and <10% moisture) (Bio-ServTM, LBS Serving 
Biotechnology, UK). We verified that all exercise sessions started after the mice had eaten 
the pellet (which consistently took ≤ 60 min). Ingestion of pellets was chosen instead of 
parenteral administration of glucose to minimise animal discomfort. To ensure similar 
conditions in all groups, all the study mice also consumed the aforementioned pellet at the 
same time of the day.  
Post-training phase 
At the end of the endurance exercise training program, all animals repeated the 
aforementioned performance test. Finally, 48 hours after the last test, mice were killed by 
intraperitoneal injection with a lethal dose of Avertin (0.2%, 0.15 ml g-1). We dissected the 
quadriceps muscles, trimmed of connective tissue, which were immediately snap-frozen in 
liquid nitrogen before storage at -80⁰C for proteomics analysis. We chose the quadriceps 
instead of other limb muscles (tibialis anterior, extensor digitorum longus, or soleus) based 






amount of sample for present and future investigations), and also on its use in recent 
research from our group aiming at identifying molecular markers of important cell functions 
(energy-sensing pathways, oxidative phosphorylation and autophagy/proteasome systems, 
oxidative damage, and sarcoplasmic reticulum Ca2+ handling) in McArdle mice (Fiuza-Luces 
et al., 2016). 
Paired comparisons were made between the maximal distance measured before and 
after the training period in the exercise and control group, in both McArdle and wild-type 
mice (Wilcoxon test). Analyses were performed with Stata statistical software (version 13, 
Stata Corp; College Station, TX) for MAC. Statistical significance level was set at p<0.05. 
Proteomic analysis 
Proteomic analysis was performed in 10 McArdle (5/group) and 8 wild-type (4/group) mice.  
Sample preparation 
Muscle samples were extracted in lysis buffer (2% SDS, 10 mM Tris(2-carboxyethyl) 
phosphine hydrochloride (TCEP) and 50 mM Tris-HCl, pH 7.5) by homogenising the tissue 
with 3 cycles at 6,500 rpm for 60 s each using a MagNA Lyser Instrument (Roche; 
Mannheim, Germany). Thereafter, samples were boiled for 5 min and incubated for 30 min 
at room temperature with agitation. Samples were centrifuged at 15,000 rpm for15 min, and 
protein concentration in the supernatant was determined with a Direct Detect IR 








Protein digestion and isobaric labelling 
For the quantitative differential analysis by liquid chromatography with tandem mass 
spectrometry (LC-MS/MS) using isobaric tags (TMT 10-plex), ~100 µg of total proteins 
were digested using the fast and secure (FASP) protocol as previously described with minor 
modifications (Cardona et al., 2015). Proteins were diluted in 7 mM urea and 0.1 mM Tris-
HCl (pH 8.5) (UA) and loaded onto 10 kDa centrifugal filter devices (NanoSep 10k Omega, 
Pall Life Sciences; Port Washington, NY). The buffer was replaced by washing filters with 
UA, and proteins were then alkylated using 500 mM iodoacetamide (IAA) in UA to 50 mM 
IAA for 30 min in the dark. The excess of alkylating reagent was eliminated by washing 
three times with UA and three additional times with 50 mM ammonium bicarbonate. 
Proteins were digested overnight at 37ºC with modified trypsin (Promega Biotech Ibérica; 
Alcobendas, Madrid, Spain) in 50 mM ammonium bicarbonate at 30:1 protein:trypsin (w/w) 
ratio. The resulting peptides were eluted by centrifugation with 50 mM ammonium 
bicarbonate (twice) and 0.5 M sodium chloride. Trifluoroacetic acid (TFA) was added to a 
final concentration of 1% and the peptides were desalted onto C18 Oasis-HLB cartridges 
(Waters; Milford, MA) and dried-down for further analysis. 
For stable isobaric labelling, the resulting tryptic peptides were dissolved in 100 mM 
tri-ethyl-ammonium bicarbonate (TEAB) buffer, and the peptide concentration was 
determined by measuring amide bonds with the Direct Detect system (Millipore Ibérica). 
Equal amounts of each peptide sample were labelled using 10-plex TMT Reagents (Thermo 
Fisher Scientific; Waltham, MA) according to the manufacturer's protocol. Peptides were 






incubation at room temperature for 2 h, the reaction was stopped with 0.5% TFA, incubated 
for 30 min, and peptides were combined. Samples were concentrated in a Speed Vac, 
desalted onto C18 Oasis-HLB cartridges and dried-down for further analysis. To increase 
proteome coverage, TMT-labelled samples were fractionated by high-pH reverse phase 
chromatography (High pH Reversed-Phase Peptide Fractionation Kit, Pierce; Rockford, IL) 
and concentrated as before. 
Protein identification and quantitation 
Labelled peptides were analysed by LC-MS/MS using a C-18 reversed phase nano-column 
(75 µm I.D. × 50 cm, 2 µm particle size, Acclaim PepMap RSLC, 100 C18; Thermo Fisher 
Scientific) in a continuous acetonitrile gradient consisting of 0–30% B in 360 min and 50–
90% B in 3 min (A=0.1% formic acid; B=90% acetonitrile, 0.1% formic acid). A flow rate of 
200 nl min-1 was used to elute peptides from the nano-column to an emitter nanospray needle 
for real time ionisation and peptide fragmentation on an Orbitrap Fusion mass spectrometer 
(Thermo Fisher Scientific). An enhanced FT-resolution spectrum (resolution=70,000) 
followed by the MS/MS spectra from the Nth most intense parent ions were analysed along 
the chromatographic run. Dynamic exclusion was set at 40 s. 
For peptide identification, all spectra were analysed with Proteome Discoverer 
(version 2.1.0.81, Thermo Fisher Scientific) using SEQUEST-HT (Thermo Fisher Scientific). 
For database searching at the Uniprot database containing all sequences from mouse and 
contaminants (April 27, 2016; 48,644 entries), the parameters were selected as follows: 
trypsin digestion with 2 maximum missed cleavage sites, precursor and fragment mass 






modifications at N-terminal and Lys residues as fixed modifications, and methionine 
oxidation as dynamic modification. Peptide identification was performed using the 
probability ratio method (Martinez-Bartolome et al., 2008) and false discovery rate (FDR) 
was calculated using inverted databases and the refined method (Navarro & Vazquez, 2009) 
with an additional filtering for precursor mass tolerance of 15 ppm (Bonzon-Kulichenko et 
al., 2015). 
Identified peptides with an FDR equal or lower than 1% FDR were used to quantify 
the relative abundance of each protein from reporter ion intensities, and statistical analysis 
of quantitative data was performed using the WSPP statistical model previously described 
(Navarro et al., 2014). In this model, protein log2-ratios are expressed as standardised 
variables; that is, in units of standard deviation according to their estimated variances (Zq 
values). 
Functional protein analysis 
Functional protein analysis of the whole set of quantified proteins was performed using a 
novel algorithm, system biology triangle (SBT), developed specifically for the analysis of 
coordinated protein responses in high-throughput quantitative proteomics experiments 
(Garcia-Marques et al., 2016). This algorithm correlates the performance of a group of 
proteins inside of a category (biological process) in terms of their quantitative behaviour 
(relative abundance); thus, changes can be detected in functional biological processes far 
beyond individual protein responses. Variations in the abundance of annotated functional 





standardised variable with that of the normal distribution, as in previous research (Isern et 
al., 2013). Individual protein changes were also considered for further analysis. 
Determination of the differentially expressed proteins 
The Kolmogorov-Smirnov test was applied to test if the data followed a normal distribution. 
Student’s t test or the Wilcoxon rank-sum test was applied to identify differentially 
expressed proteins (i.e., ‘proteins of interest’) between exercise and control groups in both 
McArdle and wild-type mice. P-values were adjusted for multiple comparisons with FDR 
correction. 
Biocomputational analysis of proteomics data 
Processing of protein expression data   
Murine proteins were converted into the corresponding human equivalent UniProt reviewed 
protein according to the following steps: i) UniProt ID automatic crossing of the murine 
proteins with human proteome with corresponding databases [InParanoid (Sonnhammer & 
Ostlund, 2015) and the Mouse Genome Database (MGD) (Blake et al., 2017)], ii) gene name 
automatic crossing of the murine proteins with human proteome with corresponding 
databases [InParanoid (Turk et al., 1990)] and iii) Manual Blast (Altschul et al., 1990), 
selecting the best reviewed match presenting at least an identity value ≥ 70% and E-value 
≤ 10-6. 
Molecular characterisation of adaptation to endurance exercise training  
Adaptation to endurance exercise training was characterised at the molecular level via 





first step, we identified the main pathophysiological processes related to ‘manifestative’ 
adaptations in the skeletal muscle in response to endurance exercise training (‘manifestative’ 
signatures), which were further characterised at the protein level to provide a final list of 
‚condition effector‛ proteins (hereafter termed ‚effectors‛) (Large Data File, part 1). Hence, 
effectors are those proteins that, according to the existing literature, have previously been 
reported to play a critical role in the process of interest for a given study viz., skeletal muscle 
adaptations to endurance exercise training [databases: PubMed, ScienceDirect and Scopus; 
key words (and combinations thereof): protein, muscle, physical adaptations, sports, exercise, 
McArdle´s disease and McArdle].  
Contextualisation of the differentially expressed proteins within “adaptation to exercise 
training” protein network 
Effector proteins were used to focus the analysis on the biological condition of interest in the 
human biological network. The direct interactions (physical interactions or functional 
relationships) among the differentially expressed proteins (in exercise vs. control groups), as 
well as the interactions between the differentially expressed proteins and the effectors of 
skeletal muscle adaptations to endurance exercise training, were assessed. Different publically 
available databases were consulted for the human protein network generation (e.g., 
Reactome, Molecular INTeraction database (MINT) and BioGrid) (Herrando-Grabulosa et 
al., 2016; Iborra-Egea et al., 2017). 
Mechanistic evaluation of the differentially expressed proteins in relation to endurance 
exercise training: artificial neuronal networks analysis  






muscle adaptations to endurance exercise training was evaluated by means of artificial 
neuronal networks (ANNs), following TPMS technology protocols (Herrando-Grabulosa et 
al., 2016; Iborra-Egea et al., 2017). This approach involves the generation of mathematical 
models of the biological processes through the use of artificial intelligence techniques. Then, 
mathematical models were solved by ANNs, which are supervised algorithms that identify 
relationships between the different nodes in the network. ANN analysis yields a score for 
each differential protein based on the validations of the prediction capacity of the 
mathematical models towards known drugs and diseases, as described in databases. The 
higher the score, the stronger is the predicted mechanistic relationship between the evaluated 
protein and the biological process. Each score is associated with a p-value that describes the 
probability of the result being a true positive one. Aiming to facilitate the understanding of 
the results, the obtained scores were divided in three categories: >76, strong (p<0.05); 40–
76, medium-strong (p=0.05–0.25); <40, weak (p>0.25). 
Proteins presenting 200+ interactions (‘sticky proteins’), or proteins that do not have 
reported interactions, were not included in the topology as they may disrupt the correct 
assessment of existing relationships (Pache et al., 2008). Relationships between the 
differentially expressed proteins and skeletal muscle adaptations to endurance exercise 
training were assessed both for individual proteins and for combinations of two proteins; 
thus, from all the reported protein interactions, the most interesting are those presenting a 
synergic effect. The synergy criteria were applied according to the approach described by 
Berenbaum (Berenbaum, 1989), in which a significant synergic effect is considered when the 






Visualisation of the protein network 
Cytoscape 3.5.1. software was used to study the representation of all the reported 
interactions (both from the significantly associated proteins and nonsignificantly associated 
proteins) according to the ANN score.  
Enrichment analysis 
The pathways and biological processes enriched within the differentially expressed proteins 
in the exercise and control groups within both McArdle and wild-type mice were assessed 
using a hypergeometric enrichment analysis approach (Rivals et al., 2007). Specifically, the 
enrichment was run over several sets of proteins, including: Gene Ontology (GO) terms 
(Biological Process, Cellular Component, Molecular Function) according to European 
Molecular Biology Laboratory (EMBL)-European Bioinformatics Institute (EBI)/UniProt-
GO (The UniProt, 2017); pathways from the Kyoto Encyclopedia of Genes and Genomes 
(KEGG) (Kanehisa et al., 2014), the Pharmacogenomics Knowledgebase (PharmGKB) 
(Whirl-Carrillo et al., 2012) and the Small Molecule Pathway Database (SMPDB) (Frolkis et 
al., 2010); pathological conditions, signatures and pathways from the Biological Effectors 
Database (BED) (Iborra-Egea et al., 2017) and the regulatory molecular mechanisms 
included in Transcriptional Regulatory Relationships Unraveled by Sentence-based Text-
mining (TRRUST) database (Han et al., 2015). Only those pathways that showed a 









The training loads were common to both McArdle and wild-type exercise groups over the 8-
week period and are shown in detail in Large Data file, part 2. The endurance exercise 
training program was successful in inducing a significant improvement in the total running 
distance of both McArdle [141 (31) metres (pre-training) vs. 167 (48) metres (post-training); 
Wilcoxon test p=0.035] and wild-type [275 (30) vs. 353 (146) metres, p=0.041] mice, whereas 
no significant change was found during the same time period in their sedentary controls [140 
(41) vs. 116 (48) metres, p=0.129 for McArdle and 302 (85) vs. 296 (103) metres, p=0.726 for 
wild-type mice]. Although the relative improvement in total running distance did not differ 
between McArdle and wild-type mice (Mann-Whitney test p=0.111), the total running 
distance of McArdle mice was ~50% lower than that of wild-type mice both before and after 
the endurance exercise intervention. Individual data (total running distance) of the mice 
used for proteomic analyses are shown in Figure 1. When expressed as Vmax, the test results 
were as follows: McArdle, exercise group: 26 (3) cm·s-1 (pre-training) vs. 29 (4) cm·s-1 (post-
training), Wilcoxon test p=0.054; wild-type, exercise group: 36 (6) (pre-training) vs. 41 (8) 
cm·s-1 (post-training), p=0.028; McArdle, sedentary control group: 26 (4) vs. 24 (5) cm·s-1, 
p=0.123; wild-type, sedentary control group: 38 (5) vs. 37 (7) cm·s-1, p=0.180. 
The body mass of the mice showed an increasing trend over time irrespective of 
genotype or intervention (exercise or control): (i) McArdle, exercise group: 20.8 (1.4) g (pre) 
and 22.0 (1.3) g (post) Wilcoxon test p=0.997; (ii) McArdle, control group: 20.8 (1.3) g (pre) 






g (post), p=0.083; wild-type, control group: 19.0 (1.9) g (pre) and 21.7 (2.1) g (post), 
p=0.805. 
Proteomics 
Proteins of interest 
Data provided by whole proteomic analysis regarding differential proteins within the 
sedentary and the trained groups of McArdle and wild-type mice, respectively, were analysed 
by applying Student’s t test and the Wilcoxon rank-sum test. A total of 74 differentially 
expressed proteins between the trained and sedentary wild-type mice and 123 differentially 
expressed proteins between the trained and sedentary McArdle mice were found (Large Data 
File, part 3). Of these differentially expressed proteins in response to endurance exercise 
training, only three were common to wild-type and McArdle mice: LIM and calponin 
homology domains-containing protein 1 (LIMCH1); poly (ADP-ribose) polymerase 1 (PARP-
1, also known as NAD+ ADP-ribosyltransferase 1 or poly (ADP-ribose) synthase 1); and 
tigger transposable element derived 4 (TIGD4). Expression of all three proteins was higher 
in endurance exercise training than in untrained conditions, in both wild-type and McArdle 
mice; however, statistical significance was not reached for any after FDR adjustment. 
Contextualisation of the differentially expressed proteins within exercise training adaptation 
The molecular characterisation of the skeletal muscle adaptations to endurance exercise 
training was carried out through the review of specialised scientific literature. A total of 76 
effector proteins were identified and classified into four groups according to their cellular 






glucose and lipid metabolism (12 proteins) and mitochondrial biogenesis and remodelling (48 
proteins), with 4 of these 76 proteins belonging to two groups (angiogenesis + mitochondrial 
biogenesis and remodeling) at the same time, cyclic AMP-dependent transcription factor 
(ATF2), steroid hormone receptor ERR1 (ESRRA, or also ERRa), mitogen-activated protein 
kinase 12 (MAPK12) and myocyte-specific enhancer factor 2A (MEF2A, or also MEF2); and 
one,  PGC-1α, belonging three groups (adaptive muscle growth + angiogenesis + 
mitochondrial biogenesis and remodeling) (Large Data File, part 1). 
The role of the differentially expressed proteins in adaptation to endurance exercise 
training was evaluated according to the molecular characterisation performed. The results of 
the analysis revealed that only one of the differentially expressed proteins in McArdle mice, 
MAPK12, had been previously related to skeletal muscle adaptations to exercise training 
(Table 1). MAPK12 is involved both in mitochondrial biogenesis and remodelling and muscle 
angiogenesis. By contrast, none of the differentially expressed proteins in wild-type mice has 
previously been reported to play a direct role in skeletal muscle adaptations to endurance 
exercise training (Table 2). However, while only one differentially expressed protein from the 
two lists (McArdle and wild-type mice) matches the effector proteins defined in the 
molecular characterisation, it is remarkable that several of them interact with many effectors 
(Tables 1 and 2). In McArdle mice, ATP synthase H+ transporting mitochondrial F1 
complex gamma polypeptide 1 (ATP5C1), MAPK12 and ATP synthase and H+ transporting 
mitochondrial F1 complex epsilon subunit (ATP5E) were related to more than 10 effectors, 
and proteasome 26S subunit, non-ATPase 14 (PSMD14), integrin-linked kinase (ILK) and 






wild-type mice, we found that poly(A) binding protein cytoplasmic 1 (PABPC1), protein 
kinase DNA-activated catalytic polypeptide (PRKDC), ribosomal protein lateral stalk 
subunit P0 (RPLP0), mitogen-activated protein kinase kinase 4 (MAP2K4) and protein 
kinase N1 (PKN1) interacted with more than 10 effectors, followed by ribosomal protein L21 
(RLP21) interacting with up to 9 different effectors. Additionally, the common differentially 
expressed protein between the two groups, PARP1, interacted with 7 different effectors, all 
of them involved in mitochondrial biogenesis and remodelling.  
 
Mechanistic evaluation of the relationship with endurance exercise training: analysis of 
artificial neuronal networks 
The potential molecular relationships between the differentially expressed proteins and 
skeletal muscle adaptations to endurance exercise training were evaluated through the 
analysis of mathematical models, to determine the possible activity relationships between 
protein sets or regions inside the network (i.e., ANN); this allowed us to provide a predictive 
score that quantifies the probability of the existence of a relationship between the evaluated 
differential proteins and network region (i.e., the different pathophysiological signatures 
characterized and adaptation to endurance exercise training as a whole). Each score is 
associated with a p-value that describes the probability of the result being a true positive 
result. To better understand the results, we divided the ranking score in four categories: 
strong (p-value <0.05), medium-strong (p-value 0.05–0.25), weak (p-value >0.25) and not 
assessed. As shown in Large Data File, part 4, it was not possible to evaluate 5 of 116 






the possible relationship between 111 proteins for McArdle mice and 68 proteins for wild-
type mice was successfully assessed. When considering the differential proteins individually, 
~28% and 22% of the proteins showed a significant relationship (strong or medium-strong 
category) with skeletal muscle adaptations to endurance exercise training in McArdle and 
wild-type mice, respectively. Moreover, when analysing the differential proteins in sets of two 
proteins, ~30% of the protein combinations showed a significant association with skeletal 
muscle adaptations to endurance exercise training, both in the McArdle and wild-type mice. 
Relationships between the differentially expressed proteins and skeletal muscle adaptations to 
endurance exercise training: individual protein evaluation 
As a result of the analysis of the relationship between individual proteins and skeletal muscle 
adaptations to endurance exercise training, a total of 33 proteins were reported to present a 
significant relationship with McArdle disease mice and 16 with wild-type mice (Table 3). 
One of the differentially expressed proteins common to both mouse groups, PARP1, 
appeared to be significantly related to skeletal muscle adaptations to endurance exercise 
training. Moreover, the assessment of the potential relationship between the proteins of 
interest and skeletal muscle adaptations to endurance exercise training signatures allowed 
the evaluation of specific subsets of the physiological processes that in some cases were not 
detected by considering the whole context. For instance, 9 proteins of interest in McArdle 
mice and 5 in wild-type mice that were predicted to be related to at least one of the 
signatures of skeletal muscle adaptations to endurance exercise training, were actually not 
found to be related to the general characterisation of skeletal muscle adaptations to 







Relationships between the differentially expressed proteins and skeletal muscle adaptations to 
endurance exercise training: association in combination of two proteins 
As a result of the analysis of the relationship between combinations of two proteins and 
skeletal muscle adaptations to endurance exercise training (Large Data File, part 4), a total 
of 2,035 protein combinations were reported to present a significant relationship in McArdle 
mice and 719 in wild-type mice. When considering only the combinations with a significant 
synergic effect (synergic effect is considered when the overall effect is >20% of the amount of 
the individual effect of the two proteins), a total of 199 and 57 protein combinations were 
found for McArdle and wild-type mice, respectively. One of the common differentially 
expressed proteins in both groups, LIMCH1, appeared to be significantly related to skeletal 
muscle adaptations to endurance exercise training in combination with other proteins.  
In order to represent the intermolecular relationships obtained regarding protein 
interactions (Tables 1 and 2 and Large Data File, part 1) and mechanistic evaluation (Large 
Data File, part 4), a visual protein interaction network map was generated for both McArdle 
(Figure 2) and wild-type (Figure 3) mice. Only the proteins with a significant relationship 
with skeletal muscle adaptations to endurance exercise training (based on ANNs score) and 
their direct interactions appear on the representations. However, closer analysis of the 
signalling networks revealed that PARP1 was more profoundly overexpressed in trained 
McArdle than in trained wild-type mice (Figures 2 and 3, respectively).  
Enrichment analysis  






undertook a hypergeometric enrichment analysis approach within the differentially expressed 
proteins in the trained and the control groups of McArdle and wild-type mice. As shown in 
Large Data File, part 5, 121 and 79 protein sets were found enriched in the comparison of 
control vs. exercise groups, both in McArdle and wild-type mice. Subsequently, a pathway 
comparison between the results obtained from both conditions was performed, obtaining 4 
common pathways and 117 and 75 proteins specifically enriched in McArdle and wild-type 
groups, respectively. The enriched protein sets common to McArdle and wild-type conditions 
corresponded to those related to high blood glucose levels and gene expression (BEDVES 
database: induction of oxidative stress diabetic neuropathies and induction of oxidative 
stress diabetic neuropathies and retinopathies; GOFUNTION database: term poly(A) RNA 
binding and the GOLOCATION referring to cytosol). 
The enriched protein sets reported within the differentially expressed proteins in 
exercise vs. control McArdle mice (Large Data File, part 5) reflect changes related to 
muscular adaptations to endurance exercise training that may be related to the improvement 
in exercise tolerance, as well as to processes associated with the pathophysiology of the 
condition. Regarding enriched protein sets related to muscular adaptations to endurance 
exercise training, there were several pathways referring to mitochondria and their functions 
(Large Data File, part 6), including GO location terms referring to several mitochondrial 
structures such as the proton-transporting ATP synthase complex (responsible for ATP 
synthesis), and GO processes such as the respiratory electron transport chain. Furthermore, 
several pathways and GO terms related to lipid and protein metabolism are also reported in 






described in Large Data File, part 7. 
Conversely, the enriched protein sets within the wild-type groups were mainly related 
to endurance exercise training-induced physiological changes due to focal adhesion, actin 
cytoskeleton reorganisation and phosphatidylinositol 3-kinase (PI3K) signalling pathway 
involvement (Large Data File, part 8). Moreover, several pathways referring to β-blocker 
activity also appeared to be enriched, possibly due to changes in catecholamine modulation 
(Large Data File, part 9). 
 
DISCUSSION  
Although McArdle disease causes ‘exercise intolerance’ (Lucia et al., 2012), under carefully 
controlled conditions, McArdle patients may perform acute exercise safely, especially if 
carbohydrate solutions are taken before exercise to bypass the metabolic blockade that 
occurs upstream of the uptake of glucose by muscle fibres (Vissing & Haller, 2003). They 
may also adapt favourably to moderate-intensity endurance exercise training (Haller et al., 
2006; Mate-Munoz et al., 2007). Yet, no study has assessed in depth the molecular signals 
associated with muscle exercise adaptations in McArdle patients and how they compare with 
those of healthy individuals. Accordingly, in the present study we aimed to identify, with no 
a priori hypothesis, the key proteins and protein networks linked to the effects of moderate-
intensity endurance exercise training in a mouse model that closely mimics the phenotype of 
McArdle patients (Nogales-Gadea et al., 2012). Unravelling the muscle metabolic adaptations 






insight into the proteome profile that characterises muscle adaptations to such type of 
training. This is an important question given that the skeletal muscle contains 50–75% of all 
the body proteins and is responsible for 30–50% of the whole body protein translation 
process (Frontera & Ochala, 2015). The majority of proteins identified here both in McArdle 
and wild-type mice control the expression of a myriad of genes related to angiogenesis, 
carbohydrate, lipid and protein metabolism, mitochondrial biogenesis and remodelling, and 
muscle growth.   
In addition to reporting the first non-pharmacological intervention in this mouse 
model, a novel finding of our study was that, like patients, McArdle mice adapt favourably 
to an individualised moderate-intensity endurance exercise training regimem (albeit without 
reaching the performance capacity of healthy mice). Yet, our results revealed a remarkable 
difference in the protein networks involved in the muscle tissue adaptations that occur with 
endurance exercise training with normal glycogen availability (wild-type mice) as compared 
with those that occur in conditions of blocked glycogenolysis (McArdle mice). Indeed, 
endurance exercise training promoted the expression of only three proteins common to both 
McArdle and wild-type mice: LIMCH1, PARP1 and TIGD4. Likely, all three proteins play a 
prominent role in the relationship between skeletal muscle plasticity and endurance exercise 
training, independent of muscle glycogen availability, which warrants further investigation. 
It is well known that during exercise, numerous stress signals are transduced to activate 
intracellular signalling pathways controlling skeletal muscle gene transcription and 
translation (Bassel-Duby & Olson, 2006; Koulmann & Bigard, 2006; Favier et al., 2008; 






stress pathways controlled by exercise. Indeed, cell contraction accelerates when LIMCH1 
promotes the assembly of actin stress fibres during cell spreading. Moreover, the absence of 
LIMCH1 expression impacts the formation of actin stress fibres as well as the stability of 
focal adhesions (Lin et al., 2017), which are fundamental structures in the union of muscle 
fibres to ensure optimal contraction and muscular distention. TIGD4 protein belongs to the 
tigger subfamily of the pogo superfamily of DNA-mediated transposons in humans. The 
latter proteins are related to DNA transposons found in fungi and nematodes and more 
distantly to transposases Tc1 and mariner, and they are very similar to the major 
mammalian B centromere protein. However, the exact function of TIGD4 remains to be 
clarified. 
PARP1 is the most characterised member of the PARP family of nuclear enzymes. 
These proteins are sensitive to changes in intracellular redox pathways, positioning the poly 
ADP-ribosylation (PARylation) reaction as an important biochemical marker of oxidative 
stress (Jungmichel et al., 2013). Whereas basal activity of PARP1 is crucial to maintain 
cellular homeostasis, its over-activity leads to an increase in protein PARylation, which in 
turn depletes intracellular NAD+ levels, leading to cell death (Ha & Snyder, 1999). Thus, 
PARP1 activity is a key sensor for cell survival. Interestingly, we found that endurance 
exercise training mediates the expression of PARP1 in both McArdle and wild-type mice, 
although being higher in trained McArdle than in trained wild-type mice. This could be due, 
at least partly, to increased muscle damage that characterises this disease.  
In general, the low overlap between groups (74 and 123 differentially expressed 






differences in the physiological adaptations to chronic endurance exercise between McArdle 
and wild-type mice, at a mechanistic level. Indeed, when we compared the protein profile 
between McArdle and wild-type mice after training, we found that McArdle mice presented a 
specific and strong expression of MAPK12 and a potentially substantial number of effector 
interactions. MAPK12 is a serine/threonine kinase that acts as an essential component of the 
MAP kinase signal transduction pathway. Also known as p38MAPK, MAPK12 is one of the 
four p38 MAPKs that play an important role in the cellular response cascade induced by 
extracellular stimuli such as proinflammatory cytokines or physical stress (Cuenda & 
Rousseau, 2007). MAPK12 plays a role in myoblast differentiation, as it is involved in the 
regulation of the expression of the solute carrier family 2 (facilitated glucose transporter), 
member 1 (SLC2A1). Further, basal glucose uptake in L6 myotubes and MAPK12-signalling 
positively regulate the expansion of transient amplifying myogenic precursor cells during 
muscle growth and regeneration (Ho et al., 2004). Our analyses suggest that MAPK12 is also 
related to mitochondrial biogenesis and remodelling, with such potentially MAPK12-
mediated improvement in mitochondrial function perhaps endeavouring to compensate for 
the deficit in energy supply owing to glycogen unavailability. By contrast, we detected a 
lower endurance exercise training-induced increase in MPAK12 protein expression in wild-
type mice.  
 Hypergeometric analysis of the highly and significantly expressed proteins in 
McArdle and wild-type mice (121 and 79 proteins, respectively) provided an enrichment in 
clinical processes that are related to the induction of oxidative stress, neuropathies and 






after endurance exercise training in McArdle mice the most widely represented functions 
were those involved in ATP synthesis and electron transport chain processes, β-oxidation of 
lipids, and different steps in lipid and protein catabolism. In addition, cell death and 
regulation of necrotic processes were also reflected in this analysis. In fact, the overexpression 
of PARP1 could be associated with rhabdomyolysis, and PARP activation is linked to 
necrosis, as shown in PARP-deficient mouse fibroblasts (Ha & Snyder, 1999). All of the 
aforementioned adaptations found in McArdle mice after endurance exercise training may be 
related to the metabolic strategies that the skeletal muscle tissue of McArdle mice deploys to 
obtain energy. Conversely, after endurance exercise training the functions that were most 
represented in wild-type mice were those related to cytoskeleton regulation and focal 
adhesions, and also PI3K and mTOR signalling pathway activation related to maintenance 
of skeletal muscle cell survival. Thus, from an overall perspective, it seems that the main 
muscle molecular adaptations to endurance exercise training in McArdle mice are more 
oriented to obtain energy for tissue regeneration in a state of energetic deficit, whereas wild-
type muscle adaptations seem to be more related to support tissue maintenance while coping 
with exercise stress stimuli. 
Our study is not without limitations. In contrast to human research, where 
performing repeated muscle biopsy sampling may be feasible, a first technical limitation is 
the impossibility to determine muscle glycogen content before and after a training session in 
the wild-type mice as a proof-of-concept for glycogen utilization. Of note, owing to the total 
inability to utilize glycogen as a fuel, massive muscle glycogen accumulation occurs in 







levels being several orders of magnitude higher than in CB7Bl/6J wild-type mice as used 
here (Nogales-Gadea et al., 2012). Moreover, we chose forced treadmill running rather than 
wheel running as a model of endurance exercise training. Although wheel running is a less 
stressful, more natural form of activity in rodents, it does not allow for the establishment of 
predetermined training loads, which was a crucial aspect of our design to ensure they were 
similar in the exercise groups. Nevertheless, researchers in charge of mouse training were well 
experienced in mouse handling such as to minimize stress in these animals. Indeed, only 
gentle tail touching was used to prompt the mice to run and no electrical stimulation was 
applied during the training sessions. Another potential limitation comes from the use of a 
single muscle type, quadriceps (with a highly glycolytic phenotype) for proteome analyses. 
Future research should determine whether comparable findings are obtained in a more 
oxidative muscle like the soleus or even in other glycolytic muscles. In this regard, although 
there are differences between muscles (even between those with a similar metabolic 
phenotype and with only subtle differences in proportion of fibre types, like the quadriceps 
and tibialis anterior) overall, both fast and slow-twitch muscles in the untrained state are 
affected by both structural degeneration and energy deficiency in McArdle mice (Krag et al., 
2016a). Along this line, recent research has identified the quadriceps muscle as having more 
compensatory adaptations to counterbalance energetic deficiency in the untrained state (i.e., 
in terms of expression of proteins involved in glucose uptake, glycogen synthesis and 
glycolysis) than other studied muscles, whether they were predominantly glycolytic (tibialis 
anterior, extensor digitorum longus) or more oxidative (soleus) (Krag et al., 2016b). Finally, 
we did not report blood serum creatine kinase levels (as an indirect marker of muscle 







In conclusion, we have determined that, akin to patients, McArdle mice responded 
favourably to moderate-intensity endurance exercise training, although their maximal aerobic 
capacity is clearly lower than that of normal peers. This suggests that glycogen availability 
is crucial for ensuring maximal endurance performance in mammals, with unavailability of 
this substrate resulting in muscles adopting a remarkably different ‘molecular strategy’ to 
cope with the training loads while ensuring cellular homeostasis during a state of energetic 
deficit. In this regard, we have identified for the first time the signalling strategies (in terms 
of signalling molecules and protein networks) that skeletal muscle employs to overcome 
blockade of glycogen breakdown during endurance exercise training, demonstrating that the 
protein network involved in muscle adaptations to such type of training greatly differs 
depending on glycogen availability (see also Figure 4 for a summary). Our findings provide a 
framework for future studies aimed at elucidating the molecular mechanisms associated with 
the most relevant identified proteins here. It would also be interesting to study in depth 
some of the proteins sets identified by the enrichment analysis; among which, PARP1, 
LIMCH1 and MAPK12 emerge as good candidates.  
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Figure 1.  Individual responses during the intervention period in maximal distance during a 









Figure 2. Visual protein interaction network map of the proteins significantly related to 
skeletal muscle adaptations to endurance exercise training according to the artificial neuronal 
network (ANN) score, and their interacting proteins, in McArdle (p.R50X/p.R50X) mice. 
The network map includes three representations of the following interactions: i) within the 
differentially expressed proteins (ovals), ii) between the differentially expressed proteins and 
skeletal muscle adaptions to endurance exercise effectors (ovals and triangles), and iii) within 
the skeletal muscle adaptations to endurance exercise effectors (triangles). Note: all the 
interactions, both from the significantly associated proteins and nonsignificantly associated 







Figure 3. Visual protein interaction network map of the proteins significantly related to 
skeletal muscle adaptations to endurance exercise training according to the artificial neuronal 
network (ANN) score, and their interacting proteins, in wild-type (wt/wt) mice. The network 
map includes include three representations of the following interactions: i) within the 
differentially expressed proteins (ovals), ii) between the differentially expressed proteins and 
skeletal muscle adaptions to endurance exercise effectors (ovals and triangles), and iii) within 







Figure 4. Integrative model summarising the main study findings. Abbreviations: LIMCH1, 
LIM and calponin homology domains-containing protein 1; MAPK12, mitogen-activated 
protein kinase 12; PARP1, poly [ADP-ribose] polymerase 1; TIGD4, tigger transposable 
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Table 1. McArdle (p.R50X/p.R50X) mice:  Summary of the interactions found between the differentially 
expressed proteins (in exercise vs. control groups) and of the protein effectors of skeletal muscle 
































P36542 ATP5C1  23 18 1 16 1 1 
P53778 MAPK12  19 15 4 12 0 3 
P56381 ATP5E  17 14 0 14 0 0 
O00487 PSMD14  18 9 2 4 3 0 
Q13418 ILK  17 9 1 7 1 1 







P07237 P4HB  11 8 0 6 2 1 
O95831 AIFM1  8 8 2 6 0 0 
P46783 RPS10  8 8 4 3 1 0 
P09874 PARP1  8 7 0 7 0 0 
Q14204 DYNC1H1  9 6 1 4 1 0 
Q9BQG0 MYBBP1A  9 6 3 3 1 1 
P0C1S8 WEE2  7 6 0 6 0 1 
O43464 HTRA2  6 6 0 6 0 1 
P42704 LRPPRC  6 6 4 3 0 1 
P35232 PHB  6 5 0 4 1 1 
P25789 PSMA4  6 3 0 2 1 0 
Q96RQ3 MCCC1  4 3 1 0 2 0 
O43615 TIMM44  4 3 0 2 1 0 
Q99816 TSG101  4 3 1 0 2 0 
Q9HAV7 GRPEL1  4 3 0 3 0 1 
Q15119 PDK2  3 3 0 0 3 0 
P02647 APOA1  8 2 0 1 1 0 
P09936 UCHL1  3 2 1 1 0 0 
Q96K17 BTF3L4  2 2 1 1 0 0 
E9PAV3 NACA  2 2 0 2 0 1 
P61221 ABCE1  2 2 1 1 0 0 
P53985 SLC16A1  2 2 0 2 0 0 
P12694 BCKDHA  2 2 0 0 2 0 






P07451 CA3  2 2 0 0 2 0 
P49257 LMAN1  6 1 0 0 1 0 
P02768 ALB  6 1 0 1 0 0 
Q06323 PSME1  4 1 0 1 0 0 
P84090 ERH  4 1 0 1 0 0 
P02671 FGA  3 1 0 0 0 1 
P01266 TG  2 1 0 1 0 1 
Q9UKY7 CDV3  2 1 0 1 0 0 
O95139 NDUFB6  2 1 0 1 0 0 
P02461 COL3A1  2 1 0 0 0 1 
O15357 INPPL1  2 1 0 0 1 0 
Q9BYN8 MRPS26  2 1 0 0 1 0 
Q9UKV0 HDAC9  2 1 0 1 0 1 
P13473 LAMP2  2 1 0 0 1 0 
P31146 CORO1A  1 1 0 0 0 1 
Q09666 AHNAK  1 1 0 1 0 1 
P13796 LCP1  1 1 0 1 0 0 
P21266 GSTM3  1 1 0 0 1 0 
Q96HC4 PDLIM5  1 1 0 0 1 0 
P17568 NDUFB7  1 1 0 1 0 0 
O43488 AKR7A2  1 1 1 0 0 0 
O60911 CTSV  1 1 0 0 1 0 
O75794 CDC123  1 1 1 0 0 0 






Symbols:  non-effectors and  effectors of skeletal muscle adaptations to endurance exercise 





Table 2. Wild-type (wt/wt) mice:  Summary of the interactions found between the differentially 
expressed proteins (in exercise vs. control groups) and of the protein effectors of skeletal muscle 































P05388 RPLP0  15 13 5 7 1 0 
P11940 PABPC1  18 12 5 6 1 0 
P78527 PRKDC  16 12 3 9 0 1 
P45985 MAP2K4  14 11 2 9 0 1 
Q16512 PKN1  14 11 3 8 0 1 
P46778 RPL21  10 9 5 4 0 0 
P62879 GNB2  9 8 1 6 1 3 
Q562R1 ACTBL2  8 8 1 7 0 0 
 






P09874 PARP1  9 7 0 7 0 0 
P15056 BRAF  9 7 1 6 0 1 
P35544 FAU  10 6 4 2 0 0 
P42677 RPS27  11 5 4 0 1 0 
P16520 GNB3  6 5 1 4 0 1 
P56192 MARS  6 5 1 4 0 0 
P08195 SLC3A2  5 5 1 3 1 1 
P06737 PYGL  5 4 1 2 1 0 
P62140 PPP1CB  6 3 0 1 2 1 
O76094 SRP72  6 2 1 0 1 0 
Q99972 MYOC  4 2 0 0 2 0 
Q13683 ITGA7  2 2 0 0 1 1 
Q6PKG0 LARP1  2 2 0 2 0 0 
O75815 BCAR3  4 1 0 1 0 0 
P07951 TPM2  2 1 0 0 1 0 
P26012 ITGB8  2 1 0 0 0 1 
Q13409 DYNC1I2  2 1 0 0 1 0 
Q15631 TSN  2 1 0 1 0 0 
O95302 FKBP9  1 1 0 0 1 0 
P07108 DBI  1 1 0 1 0 0 
Q13564 NAE1  1 1 0 1 0 0 
Q13936 CACNA1C  1 1 0 1 0 0 
Q5VZF2 MBNL2  1 1 0 0 1 0 






Q8WUD1 RAB2B  1 1 0 1 0 1 
Q9HA65 TBC1D17  1 1 0 1 0 0 
11  
Symbol:  Non effectors of skeletal muscle adaptations to exercise training among the 






Table 3. Differentially expressed proteins significantly linked to skeletal muscle adaptations 
in McArdle and wild-type mice. The higher the artificial neuronal network (ANN) predictive 
score, the stronger is the relationship between the protein and skeletal muscle adaptations to 
endurance exercise training or its motives. 
 































































APOA1 88% 5% 68% 17% 65 % LARP1 72% 13% 15% 16% 14 % 
MAPK1
2 
84% 52% 5% 64% 92 % DYNC1
I2 
71% 5% 10% 16% 52 % 
CDV3 77% 16% 14% 6% 74 % PARP1 71% 37% 19% 27% 71 % 
LRPPR
C 
77% 70% 5% 67% 37 % BRAF 70% 5% 13% 62% 65 % 
TSG101 75% 61% 5% 11% 58 % GNB2 69% 27% 70% 55% 70 % 
ERH 72% 5% 14% 11% 54 % INCEN
P 
67% 5% 5% 5% 23 % 
PARP1 71% 37% 19% 27% 71 % CUTA 63% 5% 12% 16% 16 % 
CAPN2 71% 5% 17% 5% 67 % UBE2V
2 
63% 5% 5% 16% 11 % 
CORO1
A 
71% 5% 5% 64% 49 % GNB3 57% 12% 5% 68% 64 % 
DYNC1
H1 
71% 33% 5% 24% 31 % MYOC 57% 5% 68% 5% 5 % 
PDK2 71% 5% 64% 18% 14 % CACN
A1C 
54% 13% 15% 17% 65 % 
CA3 71% 15% 66% 18% 5 % ASB15 53% 6% 5% 16% 64 % 
PHB 70% 8% 5% 5% 26 % PPP1C
B 
48% 17% 5% 65% 18 % 
TF 70% 6% 5% 16% 15 % APOH 44% 6% 16% 5% 25 % 
AIFM1 70% 5% 8% 5% 14 % NAE1 43% 5% 7% 16% 5 % 








68% 6% 6% 6% 58 % TSN 29% 15% 16% 16% 44 % 
B2M 67% 7% 5% 11% 14 % RPL21 22% 59% 6% 16% 5 % 
ALB 65% 9% 8% 11% 48 % FAU 19% 60% 6% 16% 48 % 
SERPI
NA1 
65% 5% 5% 5% 48 % RPLP0 17% 56% 5% 16% 34 % 
GSTM3 64% 5% 6% 16% 40 % SRP72 17% 36% 67% 5% 50% 
HDAC9 64% 6% 6% 69% 38 % - - - - - - 
AK6 63% 6% 5% 16% 13 % - - - - - - 
MYBB
P1A 
61% 69% 5% 66% 26 % - - - - - - 
FGA 61% 6% 10% 16% 5 % - - - - - - 
AP2A2 55% 32% 16% 11% 5 % - - - - - - 
PSAP 54% 5% 8% 6% 5 % - - - - - - 
P4HB 53% 15% 5% 16% 55 % - - - - - - 
CCT3 48% 28% 5% 11% 65 % - - - - - - 
UCHL1 45% 16% 5% 16% 40 % - - - - - - 
ATP5C
1 
44% 5% 5% 5% 55 % - - - - - - 
ATP5E 42% 5% 13% 10% 53 % - - - - - - 
LMAN1 42% 5% 5% 16% 5 % - - - - - - 
NDUFB
7 






PSMA4 35% 6% 17% 18% 51 % - - - - - - 
NDUFB
6 
30% 6% 16% 11% 48 % - - - - - - 
SEC13 28% 6% 8% 5% 62 % - - - - - - 
MTM1 25% 23% 5% 10% 59 % - - - - - - 
IGKC 23% 9% 5% 19% 57 % - - - - - - 
LAMA5 22% 16% 15% 7% 50 % - - - - - - 
RPS10 19% 59% 8% 16% 18 % - - - - - - 
TUBAL
3 
18% 5% 7% 16% 64% - - - - - - 
 ANN score (strong relationship) >76%  p-value < 0.05   ANN score 40-76 (strong-medium) 



















Part 1. Summary of skeletal muscle adaptations to endurance exercise training 
through the review of specialised scientific literature   
 Effector Protein (Name)  
Effector Protein  MOTIVE ID  
(Short Name)  
Adaptive muscle 
growth  
40S ribosomal protein S6  RPS6 (rpS6)  
E3 ubiquitin-protein ligase TRIM63  TRIM63  
Elongation factor 2  EEF2  
Eukaryotic translation initiation factor 4B  IF4B  
Eukaryotic translation initiation factor 4E  EIF4E (eIF4E )  
Eukaryotic translation initiation factor 4E-
binding protein 1  
EIF4EBP1 
(4EBP1)  
Forkhead box protein O3  FOXO3  
Growth/differentiation factor 8  MSTN  
Mechanistic target of rapamycin  mTOR  
Peroxisome proliferator-activated receptor 







Phospholipase D1  PLD1  
Phospholipase D2  PLD2  
Ribosomal protein S6K 1  RPS6KB1 
(p70S6K1)  
Ribosomal protein S6K 2  RPS6KB2 
(p70S6K2)  
Angiogenesis  
Cyclic AMP-dependent transcription factor 
ATF-2  
ATF2  
Mitogen-activated protein kinase 12  MAPK12 (p38g)  
Myocyte-specific enhancer factor 2A  MEF2A (MEF2)  
Nitric oxide synthase, endothelial  NOS3  
Peroxisome proliferator-activated receptor 
gamma coactivator 1-alpha  
PGC-1-alpha  
Steroid hormone receptor ERR1  ESRRA (ERRa)  
Thrombospondin-1  TSP-1  
 Vascular endothelial growth factor A  VEGFA  
Glucose and lipid 
metabolism 
Alpha-enolase  ENO1  






adaptations  Carnitine O-palmitoyltransferase 1, 
muscle isoform  
CPT1B  
Fatty acid-binding protein, heart  FABP3 
(FABPH)  
Glycogen phosphorylase, muscle form  PYGM  
Glyoxalase I (Lactoylglutathione lyase)  GLO1  
Muscle form hexokinase  HK2  
Muscle-type aldolase  ALDOA  
Platelet glycoprotein 4  FAT/CD36  
Pyruvate dehydrogenase E1 component 




Pyruvate dehydrogenase E1 component 
subunit beta, mitochondrial  
PDHB (PDHb)  
Solute carrier family 2, facilitated glucose 






5-aminolevulinate synthase, nonspecific, 
mitochondrial  
ALAS1  
5'-AMP-activated protein kinase catalytic 









Cytochrome c oxidase subunit 4 isoform COX4I2  
5'-AMP-activated protein kinase catalytic 
subunit alpha-2  
PRKAA1 
(AMPKa2)  








ATP synthase subunit beta, 
mitochondrial  
ATP5B  
BCL2/adenovirus E1B 19 kDa protein-
interacting protein 3  
BNIP3  
BCL2/adenovirus E1B 19 kDa protein-
interacting protein 3-like  
BNIP3L  
Cyclic AMP-dependent transcription 
factor ATF-2  
ATF2  
Cytochrome c oxidase subunit 1  MT-CO1  
Cytochrome c oxidase subunit 2  MT-CO2  
Cytochrome c oxidase subunit 3  MT-CO3  
Cytochrome c oxidase subunit 4 isoform 







2, mitochondria  
Cytochrome c oxidase subunit 5A, 
mitochondrial  
COX5A  
Cytochrome c oxidase subunit 5B, 
mitochondrial  
COX5B  
Cytochrome c oxidase subunit 6A1, 
mitochondrial  
Cox6a1  
Cytochrome c oxidase subunit 6A2, 
mitochondrial  
Cox6a2  
Cytochrome c oxidase subunit 6B1  Cox6b1  
Cytochrome c oxidase subunit 6B2  Cox6b2  
Cytochrome c oxidase subunit 6C  Cox6c  
Cytochrome c oxidase subunit 7A-related 
protein, mitochondrial  
Cox7r  
Cytochrome c oxidase subunit 7A1, 
mitochondrial  
Cox7a1  
Cytochrome c oxidase subunit 7A2, 
mitochondrial  
Cox7a2  







Cytochrome c oxidase subunit 7C, 
mitochondrial  
Cox7c  
Cytochrome c oxidase subunit 8A, 
mitochondrial P  
Cox8a  
Cytochrome c oxidase subunit 8C, 
mitochondrial  
Cox8c  
E3 ubiquitin-protein ligase parkin  PARK2 
(PARKIN)  
FUN14 domain-containing protein 1  FUNDC1  
Microtubule-associated proteins 1A/1B 
light chain 3B  
MAP1LC3B 
(LC3)  
Mitochondrial fission 1 protein  FIS1  
Mitofusin-1  MFN1  
Mitofusin-2  MFN2  
Mitogen-activated protein kinase 11  MAPK11 
(p38b)  







Mitogen-activated protein kinase 13  MAPK13 
(p38d)  
Mitogen-activated protein kinase 14  MAPK14 
(p38a)  
Myocyte-specific enhancer factor 2A  MEF2A (MEF2 
)  
 NAD-dependent protein deacetylase 
sirtuin-1  
SIRT1  
Nuclear respiratory factor 1  NRF-1  
Nuclear respiratory factor 2 (GA-binding 
protein subunit beta-1)  
NRF-2  
Peroxisome proliferator-activated 
receptor gamma coactivator 1-alpha  
PGC-1-alpha  
PTEN-induced putative kinase protein 1  PINK1  
Putative cytochrome c oxidase subunit 
7A3, mitochondrial  
Cox7a3  
Serine/threonine-protein kinase ULK1  ULK1 (ATG1 )  











Part 2. Summary of training loads in the two exercise groups (McArdle and wild-











































































































































32   
(30, 
35)  
35   
(30, 
40)  
41   
(35, 
45)  
40   
(40, 
40)  
43   
(35, 
50)  
44   
(35, 
50)  
45   
(40, 
50)  








227   
(207, 
255)  
264   
 (219, 
305)  
328   
(292, 
364)  
337   
(324, 
362)  







389   
(261, 
462)  






303   
(277, 
344)  
339   
(283, 
392)  
423   
(371, 
473)  
432   
 (385,  
447)  
440   
(355, 
492)  
446   
(434, 
471)  
463   
 (383,  
481)  




Data are mean and range (min, max) for the core part of all the sessions within each 
week. * determined as % of the velocity reached at the end of the maximal 
performance test performed at the start of the study (abbreviated as Vmax in the 
text). Of note, training loads decreased in the two days of the 8th week (Wednesday 











Part 3. List of the differentially expressed proteins between the trained and 
sedentary McArdle mice (n=123) and the trained and sedentary wild-type mice 
(n= 74)  
McArdle mice  Wild-type mice  
Mouse UniProt ID  
Human  
Uniprot ID  
Gene Name  




Uniprot ID  
Gene Name  
O08710  P01266  TG  P28028  P15056  BRAF  
O08529  P17655  CAPN2  Q9QZK2  O75815  BCAR3  
F6TQW2  -  -  B1ATL6  P45985  MAP2K4  
Q8VCP8  Q9Y3D8  AK6  Q99LH9  Q7L8J4  SH3BP5L  
Q5HZY7  O75348  ATP6V1G1  E0CXQ2  P0CG20  PRR35  
Q9Z0P5  Q6IBS0  TWF2  Q3UK27  Q13564  NAE1  
Q5SSW2  Q14997  PSME4  Q8BFZ3  Q562R1  ACTBL2  
Q9DC11  Q6UX71  PLXDC2  Q9D404  Q9NWU1  OXSM  
Q9JHU4  Q14204  DYNC1H1  O09167  P46778  RPL21  
Q8CHH9  Q92599  SEPT8  Q920Q6  Q96DH6  MSI2  
Q5RKZ7  Q9NZB8  MOCS1  P47802  Q13505  MTX1  
Q545F5  P56381  ATP5E  Q54AE3  P16520  GNB3  
P48774  P21266  GSTM3  P59279  Q8WUD1  RAB2B  
P70670  E9PAV3  NACA  Q9WU62  Q9NQS7  INCENP  
Q9Z0X1  O95831  AIFM1  P62880  P62879  GNB2  






D3YUB6  Q5XKL5  BTBD8  Q5M8R8  P05388  RPLP0  
O08663  P50579  METAP2  Q9ET01  P06737  PYGL  
Q61838  P20742  PZP  Q8BUZ3  Q8IY51  TIGD4  
Q8C5W0  Q96JQ2  CLMN  Q8VHS6  Q8WXK1  ASB15  
P01864  -  -  A2BFF7  Q13409  DYNC1I2  
P01887  P61769  B2M  Q99K23  Q9NUQ7  UFSP2  
Q3UX10  A6NHL2  TUBAL3  Q6ZQ58  Q6PKG0  LARP1  
A0A0A6YW72  Q6V1P9  DCHS2  Q80X76  -  -  
P08121  P02461  COL3A1  Q8BGF0  O00534  VWA5A  
O88196  P53804  TTC3  O35206  P39059  COL15A1  
P01837  P01834  IGKC  P21845  Q15661  TPSAB1  
P97371  Q06323  PSME1  Q5XPI3  Q5XPI4  RNF123  
Q4VAA2  Q9UKY7  CDV3  Q62348  Q15631  TSN  
Q14C59  Q86T26  TMPRSS11B  Q9D2M8  Q15819  UBE2V2  
Q921I1  P02787  TF  E9Q740  O76094  SRP72  
Q9R1P0  P25789  PSMA4  Q9CQ89  O60888  CUTA  
P05213  P68363  TUBA1B  E9PYH6  O15047  SETD1A  
P84089  P84090  ERH  Q01815  Q13936  CACNA1C  
 
Q3U1N0  P31146  CORO1A  Q8BL65  Q6H8Q1  ABLIM2  
Q8R0Y8  Q86VD7  SLC25A42  P62862  P35544  FAU  






Q9CQH7  Q96K17  BTF3L4  P28650  Q8N142  ADSSL1  
Q8R404  Q5XKP0  MIC13  G3X9Q1  Q13683  ITGA7  
O35857  O43615  TIMM44  P97822  Q9BTT0  ANP32E  
P01867  -  -  A6H6K1  Q9BXN1  ASPN  
Q9R0P9  P09936  UCHL1  P11103  P09874  PARP1  
Q4VAE3  Q6PI78  TMEM65  Q60718  Q99965  ADAM2  
Q6P549  O15357  INPPL1  P10852  P08195  SLC3A2  
F6ZAP6  -  -  Q0VBD0  P26012  ITGB8  
P62984  P62987  UBA52  P62141  P62140  PPP1CB  
O09174  Q9UHK6  AMACR  P29341  P11940  PABPC1  
E9PYB0  Q8IVF2  AHNAK2  Q8C4G9  Q86SQ6  ADGRA1  
Q811B1  Q86Y38  XYLT1  Q8C0K5  P16260  SLC25A16  
Q80ZW2  Q8WUY1  THEM6  Q3UH68  Q9UPQ0  LIMCH1  
Q9D0F3  P49257  LMAN1  Q69ZX8  O94929  ABLIM3  
E9Q616  Q09666  AHNAK  P97313  P78527  PRKDC  
Q9WUU7  Q9UBR2  CTSZ  P31786  P07108  DBI  
P09103  P07237  P4HB  Q01339  P02749  APOH  
P16015  P07451  CA3  Q8VED9  Q3ZCW2  LGALSL  
O35593  O00487  PSMD14  Q6R0H7  O95467  GNAS  
Q542A1  Q9UHQ4  BCAP29  A2AIM4  P07951  TPM2  
Q9EQZ7  Q9UQ26  RIMS2  Q9CXJ4  Q9NUT2  ABCB8  






Q8R092  Q9BWL3  C1orf43  Q6ZWU9  P42677  RPS27  
Q99J47  Q6IAN0  DHRS7B  Q9EPM5  Q9H7C4  SYNC  
Q546G4  P02768  ALB  P70268  Q16512  PKN1  
Q80ZS3  Q9BYN8  MRPS26  Q6IRU7  Q5JTW2  CEP78  
P61222  P61221  ABCE1  Q8CHG3  Q8IWJ2  GCC2  
Q8CI51  Q96HC4  PDLIM5  Q32NZ6  Q6UXY8  TMC5  
A2AE45  -  -  Q1XH17  Q6ZMU5  TRIM72  
Q9D1M0  P55735  SEC13  Q9Z247  O95302  FKBP9  
Q99NB1  Q9NUB1  ACSS1  Q62205  Q15858  SCN9A  
Q8BUZ3  Q8IY51  TIGD4  Q8BG95  O60237  PPP1R12B  
Q62087  Q15166  PON3  B0QZF7  Q8NCQ7  PROCA1  
O88492  Q96Q06  PLIN4  Q8BYH7  Q9HA65  TBC1D17  
O55222  Q13418  ILK  P11627  P32004  L1CAM  
Q3V1H3  Q6MZM0  HEPHL1  O70624  Q99972  MYOC  
Q3U4U6  P49368  CCT3  E9QB02  P56192  MARS  
Q9JIY5  O43464  HTRA2  
      
      P06728  P06727  APOA4  
 
Q544H9  Q96T49  PPP1R16B  
P53986  P53985  SLC16A1  
A3KGG4  A7MBM2  DISP2  






Q9JKF7  Q9NYK5  MRPL39  
P06330  -  -  
Q8R2Q4  Q969S9  GFM2  
Q9JK42  Q15119  PDK2  
Q9CR61  P17568  NDUFB7  
Q8CG76  O43488  AKR7A2  
Q6PB66  P42704  LRPPRC  
P50136  P12694  BCKDHA  
O08911  P53778  MAPK12  
Q1RLL3  Q8IYJ1  CPNE9  
Q8C2K5  Q86YV0  RASAL3  
Q80YR9  Q8IXT5  RBM12B  
Q4FJQ6  P35237  SERPINB6  
Q61001  O15230  LAMA5  
Q61187  Q99816  TSG101  
Q8K3C3  Q8WZA0  LZIC  
P06797  O60911  CTSV  
A2AAJ9  Q5VST9  OBSCN  
Q3UZA1  Q6JBY9  RCSD1  
Q99N13  Q9UKV0  HDAC9  
Q8BGK2  Q8NDY3  ADPRHL1  







P17047  P13473  LAMP2  
D3YX79  -  -  
Q8CII2  O75794  CDC123  
E9PV24  P02671  FGA  
P17427  O94973  AP2A2  
Q99L88  Q13884  SNTB1  
P11103  P09874  PARP1  
Q9JHL1  Q15599  SLC9A3R2  
Q3U2W2  Q9BQG0  MYBBP1A  
Q9WV96  Q9Y5J6  TIMM10B  
Q66JT0  P0C1S8  WEE2  
A2AKU9  P36542  ATP5C1  
A2AP31  O95139  NDUFB6  
P33173  Q12756  KIF1A  
Q921I2  Q8TBB5  KLHDC4  
Q8BTS4  Q7Z3B4  NUP54  
D3YU22  Q9UPQ0  LIMCH1  
Q61233  P13796  LCP1  
P22599  P01009  SERPINA1  
Q99MR8  Q96RQ3  MCCC1  










Part 4. Number of proteins reported for each artificial neuronal network (ANN) 
category in relation to skeletal muscle adaptations to endurance exercise training 
in McArdle and wild-type mice. Information is given for proteins individually 
(‘individual’), in combination (‘combined’) and both (‘total’)  
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Total  116  100%  5 671  100% 5 787 100%  73  100% 2 278  100% 2 
351 100%  
3  
         
 
Part 5. Summary of all the enriched protein sets (the corresponding database is also 
indicated)   
Source  
 McArdle  
mice  
Wild-type   
mice  
BED   7  0  
BED Motives   9  5  
BED Pathways   5  3  
GO Function   7  3  
GO Location   35  1  
GO Process      55  2  
PharmGKB   2  1  
TRRUST    1  0  
KEGG   0  13  






TOTAL   121  79  
  
Abbreviations: BED, Biological Effectors Database; GO, Gene Ontology; KEGG, Kyoto 
Encyclopedia of Genes and Genomes; PharmGKB, Pharmacogenomics Knowledgebase; 
SMPDB, Small Molecule Pathway Database; TRRUST, Transcriptional Regulatory 
Relationships Unraveled by Sentence-based Text-mining database.   
  
  
Part 6. Enriched protein sets related to mitochondrial function in McArdle mice   
Source  Set name  
BED Pathways  Oxidative phosphorylation (OXPHOS)  
GO Function ID  Proton-transporting ATP synthase activity, rotational mechanism  
GO Location  Mitochondrial crista junction  
GO Location  Mitochondrial inner membrane  
GO Location  Mitochondrial intermembrane space  
GO Location  Mitochondrial matrix  
GO Location  Mitochondrial proton-transporting ATP synthase complex  
GO Location  Mitochondrial proton-transporting ATP synthase complex, catalytic core 
F(1)  






GO Process   Mitochondrion organisation  
GO Process  Protein targeting to mitochondrion  
GO Process  Respiratory electron transport chain  
Abbreviations: BED, Biological Effectors Database; GO, Gene Ontology;   
  
 Part 7. Enriched protein sets related to muscle structure and growth    
Source  Set name  
GO Location  costamere  
GO Location  cytoskeleton  
GO Location  focal adhesion  
GO Location  membrane  
GO Location  actin filament  
GO Process  cell-matrix adhesion  
GO Process  integrin-mediated signaling pathway  
GO Process  positive regulation of Rho protein signal transduction  
GO Process  regulation of actin cytoskeleton organization  
GO Process  mitotic cell cycle  







GO Process  regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle  
Abbreviations GO, Gene Ontology.  
 
Part 8. Summary of the enriched protein sets related to increase in muscle size and 
function, and neuromodulation   
   
SOURCE  SET_NAME  
KEGG  04510 _Focal adhesión  
KEGG  04810 _Regulation of actin cytoskeleton  
KEGG  04151 _PI3K-Akt signalling pathway  
BED Pathways  Gastrointestinal smooth muscle sustained contraction  
BED Pathways  Smooth muscle relaxation  
BED Pathways  Vascular smooth muscle contraction  
KEGG  04270 _Vascular smooth muscle contraction  
GO Function  poly(U) RNA binding  
GO Function  translation activator activity  
GO Process  small GTPase mediated signal transduction  
GO Process  translational initiation  
KEGG  03015 _mRNA surveillance pathway  






KEGG  04713 _Circadian entrainment  
KEGG  04151 _PI3K-Akt signaling pathway  
KEGG  04720 _Long-term potentiation  
KEGG  04726 _Serotonergic synapse  
KEGG  04727 _GABAergic synapse  
KEGG  04728_Dopaminergic synapse  
Abbreviations: BED, Biological Effectors Database; GO, Gene Ontology; KEGG, Kyoto 
Encyclopedia of Genes and Genomes.  
  
Part 9. Summary of the enriched protein set related to catecholamine modulation 
within wild-type (wt/wt) mice. Set sources are also indicated    
Source  Set name  Source  Set name  
PHARMKB  
[PA2024] Beta-agonist/beta-blocker pathway, 
pharmacodynamics  
SMPDB  [ SMP00367] Carvedilol action pathway  
SMPDB  [SMP00296] Acebutolol action pathway  SMPDB  [ SMP00368] Labetalol action pathway  
SMPDB  [SMP00297] Alprenolol action pathway  SMPDB  [ SMP00375] Verapamil action pathway  
SMPDB  [SMP00298] Atenolol action pathway  SMPDB  [ SMP00376] Amlodipine action pathway  
SMPDB  [SMP00299] Betaxolol action pathway  SMPDB  [ SMP00377] Felodipine action pathway  
SMPDB  [SMP00300] Bisoprolol action pathway  SMPDB  [ SMP00378] Isradipine action pathway  
SMPDB  [SMP00301] Esmolol action pathway  SMPDB  [ SMP00379] Nifedipine action pathway  






SMPDB  [SMP00303] Nadolol action pathway  SMPDB  [ SMP00381] Nisoldipine action pathway  
SMPDB  [SMP00304] Oxprenolol action pathway  SMPDB  [ SMP00382] Nitrendipine action pathway  
SMPDB  [SMP00305] Penbutolol action pathway  SMPDB  [ SMP00588] Muscle/heart contraction  
SMPDB  [SMP00306] Pindolol action pathway  SMPDB  [ SMP00619] Felodipine metabolism pathway  
SMPDB  [SMP00307] Propranolol action pathway  SMPDB  [ SMP00657] Bopindolol action pathway  
SMPDB  
[SMP00320] Intracellular signaling through 
adenosine receptor A2a and adenosine  
SMPDB  [ SMP00658] Carteolol action pathway  
SMPDB  
[SMP00321] Intracellular signaling through 
adenosine receptor A2b and adenosine  
SMPDB  [ SMP00659] Timolol action pathway  
SMPDB  [SMP00323] Quinidine action pathway  SMPDB  [ SMP00660] Sotalol action pathway  
SMPDB  
[SMP00324] Procainamide (antiarrhythmic) 
action pathway  
SMPDB  [ SMP00661] Epinephrine action pathway  
SMPDB  [SMP00325] Disopyramide action pathway  SMPDB  [ SMP00662] Dobutamine action pathway  
SMPDB  
[SMP00326] Fosphenytoin (antiarrhythmic) 
action pathway  
SMPDB  [ SMP00663] Isoprenaline action pathway  
SMPDB  [SMP00328] Lidocaine (antiarrhythmic) action   SMPDB  [ SMP00664] Arbutamine action pathway  
SMPDB  [SMP00329] Mexiletine action pathway  SMPDB  [ SMP00665] Amiodarone action pathway  
SMPDB  [SMP00330] Tocainide action pathway  SMPDB  [ SMP00666] Levobunolol action pathway  
SMPDB  [SMP00331] Flecainide action pathway  SMPDB  [ SMP00667] Metipranolol action pathway  
SMPDB  [SMP00332] Ibutilide action pathway  SMPDB  [ SMP00668] Bevantolol action pathway  
SMPDB  [SMP00359] Diltiazem action pathway  SMPDB  [ SMP00669] Practolol action pathway  
SMPDB  [SMP00366] Nebivolol action pathway  SMPDB  [SMP00670] Bupranolol action pathway  
 
